These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


520 related items for PubMed ID: 18955098

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S, Chaturvedi VK, Rai A, Saini M, Chandra R, Saini Y, Gupta PK.
    Vaccine; 2007 May 16; 25(20):4020-8. PubMed ID: 17391817
    [Abstract] [Full Text] [Related]

  • 6. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W, Zhang Y, Wang S.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar 16; 15(1):61-5. PubMed ID: 12526306
    [Abstract] [Full Text] [Related]

  • 7. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P, Jacob Y, Desmézières E, Tordo N.
    Dev Biol (Basel); 2000 Mar 16; 104():151-7. PubMed ID: 11713814
    [Abstract] [Full Text] [Related]

  • 8. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ, Yang Y, Wilson JM, Ertl HC.
    Virology; 1996 May 01; 219(1):220-7. PubMed ID: 8623532
    [Abstract] [Full Text] [Related]

  • 9. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli.
    Motoi Y, Sato K, Hatta H, Morimoto K, Inoue S, Yamada A.
    Vaccine; 2005 Apr 27; 23(23):3026-32. PubMed ID: 15811649
    [Abstract] [Full Text] [Related]

  • 10. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W, Obeid OE, Steward MW.
    Virology; 2000 Jun 20; 272(1):98-105. PubMed ID: 10873752
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.
    Houimel M, Dellagi K.
    J Virol Methods; 2009 Nov 20; 161(2):205-15. PubMed ID: 19559727
    [Abstract] [Full Text] [Related]

  • 14. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation.
    Metlin AE, Rybakov SS, Gruzdev KN, Neuvonen E, Cox J, Huovilainen A.
    Dev Biol (Basel); 2006 Nov 20; 125():33-7. PubMed ID: 16878458
    [No Abstract] [Full Text] [Related]

  • 15. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein.
    van der Heijden RW, Langedijk JP, Groen J, UytdeHaag FG, Meloen RH, Osterhaus AD.
    J Gen Virol; 1993 Aug 20; 74 ( Pt 8)():1539-45. PubMed ID: 7688410
    [Abstract] [Full Text] [Related]

  • 16. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T, Briggs DJ, Davis RD, Moore SM, Xiang Z, Ertl HC, Fu ZF.
    Vaccine; 2000 Jun 15; 18(25):2804-7. PubMed ID: 10812222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y, Rowley KJ, Booth BJ, Sloan SE, Ambrosino DM, Babcock GJ.
    Antiviral Res; 2011 Aug 15; 91(2):187-94. PubMed ID: 21693135
    [Abstract] [Full Text] [Related]

  • 19. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J, Rupprecht CE, Mans J, Viljoen GJ, Nel LH.
    Vaccine; 2007 May 22; 25(21):4213-22. PubMed ID: 17434244
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.